Volume 15, Number 6—June 2009
CME ACTIVITY - Perspective
Past, Present, and Possible Future Human Infection with Influenza Virus A Subtype H7
|Location||Year||Subtype||IVPI||No. human infections||Symptoms||References|
|USA (New York)||2003||H7N2||LPAI||1||Respiratory||(11)|
|The Netherlands||2003||H7N7||HPAI||89||Conjunctivitis, respiratory||(6,13)|
|Canada (British Columbia)||2004||H7N3||LPAI/HPAI||2||Conjunctivitis, respiratory||(14,15)|
|UK (Wales)||2007||H7N2||LPAI||4||Conjunctivitis, respiratory||(17)|
*IVPI, intravenous pathogenicity index (1); LPAI, low pathogenicity avian influenza; HPAI, highly pathogenic avian influenza.
†Serologic evidence only.
- World Organisation for Animal Health. Highly pathogenic avian influenza (fowl plague). In: Cullen GA, Linnance S, editors. Manual of standards for diagnostic tests and vaccines. 3rd ed. Paris: The Organisation; 1996. p. 155–60.
- Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Human infection with influenza H9N2. Lancet. 1999;354:916–7.
- Taubenberger JK. Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter. Proc Natl Acad Sci U S A. 1998;95:9713–5.
- Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–40.
- Writing Committeee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A(H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358:261–73.
- Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004;101:1356–61.
- Banks J, Speidel EC, McCauley JW, Alexander DJ. Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses. Arch Virol. 2000;145:1047–58.
- Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996;348:901–2.
- Banks J, Speidel E, Alexander DJ. Characterisation of an avian influenza A virus isolated from a human—is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch Virol. 1998;143:781–7.
- Centers for Disease Control and Prevention. Update: influenza activity—United States, 2003–04 season. MMWR Morb Mortal Wkly Rep. 2004;53:284–7.
- Centers for Disease Control and Prevention. Update: influenza activity—United States and worldwide, 2003–04 season, and composition of the 2004–05 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2004;53:547–52.
- Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J Infect Dis. 2005;192:1318–22.
- Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587–93.
- Hirst M, Astell CR, Griffith M, Coughlin SM, Moksa M, Zeng T, Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis. 2004;10:2192–5.
- Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004;10:2196–9.
- Nguyen-Van-Tam JS, Nair P, Acheson P, Baker A, Barker M, Bracebridge S, Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006;11:E060504.2.
- Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007;12:E070531.2.
- Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol. 2004;33:393–404.
- DeLay PD, Casey HL, Tubiash HS. Comparative study of fowl plague virus and a virus isolated from man. Public Health Rep. 1967;82:615–20.
- Campbell CH, Webster RG, Breese SS Jr. Fowl plague virus from man. J Infect Dis. 1970;122:513–6.
- Taylor HR, Turner AJ. A case report of fowl plague keratoconjunctivitis. Br J Ophthalmol. 1977;61:86–8.
- Webster RG, Geraci J, Petursson G, Skirnisson K. Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med. 1981;304:911.
- Lang G, Gagnon A, Geraci JR. Isolation of an influenza A virus from seals. Arch Virol. 1981;68:189–95.
- Meijer A, Bosman A, van de Kamp EE, Wilbrink B, van Beest Holle Mdu R, Koopmans M. Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test. J Virol Methods. 2006;132:113–20.
- Pappas C, Matsuoka Y, Swayne DE, Donis RO. Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol. 2007;14:1425–32.
- United States Animal Health Association. Report of the Committee on Transmissible Diseases of Poultry and Other Avian Species. Richmond (VA): The Association; 2007.
- Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, Lee CW, Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis. 2004;10:693–9.
- Dudley JP. Public health and epidemiological considerations for avian influenza risk mapping and risk assessment. Ecology and Society. 2008;13:21.
- Skowronski DM, Li Y, Tweed SA, Tam TW, Petric M, David ST, Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ. 2007;176:47–53.
- Kuhne M, Morgan O, Ellis J, Nair P, Wreghitt TG, Curran MD, Human antibody response to avian influenza A (H7N3) virus during an outbreak in poultry in Norfolk, United Kingdom. Options for the Control of Influenza VI (abstract P326); 2007.
- Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol. 2007;81:11139–47.
- de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol. 2005;79:12401–7.
- Spackman E, Senne DA, Davison S, Suarez DL. Sequence analysis of recent H7 avian influenza viruses associated with three different outbreaks in commercial poultry in the United States. J Virol. 2003;77:13399–402.
- Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc Natl Acad Sci U S A. 2008;105:7558–63.
- Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML. Distinct pathogenesis of Hong Kong–origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol. 2000;74:1443–50.
- Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF, Osterhaus AD, The molecular basis of the pathogenicity of the dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis. 2007;196:258–65.
- Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology. 2008;378:123–32.
- Ilyushina NA, Govorkova EA, Russell CJ, Hoffmann E, Webster RG. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol. 2007;88:1266–74.
- Ilyushina NA, Govorkova EA, Webster RG. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology. 2005;341:102–6.
- Centers for Disease Control and Prevention. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. 2006 [cited 2009 Mar 1]. Available from http://www.cdc.gov/flu/avian/professional/protect-guid.htm
Page created: September 24, 2012
Page updated: September 24, 2012
Page reviewed: September 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.